Eris Lifesciences Limited

NSE:ERIS.NS

1647.4 (INR) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20252024202320222021202020192018201720162015201420132012
Operating Activities:
Net Income 3,518.43,919.834,046.434,421.983,944.973,313.53,173.583,122.292,637.721,544.441,094.15983.25831.39369.43
Depreciation & Amortization 3,154.61,826.051,170.88647.05429.85502.58363.54256.42237.39203.56155.1447.6834.8532.44
Deferred Income Tax 00-809.69-976.58-670.94-585.06-980.190000000
Stock Based Compensation 91.37.531.2113.5511.216.6116.520000000
Change In Working Capital 580.3-987.39-1,755.36-299.0153.27-527.06-532.38-221.54-163.65-82.05-80.63207.26-160.5-107.96
Accounts Receivables -91.1-570.93-1,171.38-204.8158.96-747.86-175.54-91.59-138.36-17.03-13.26-57.44-21.5-0.02
Inventory -943.6-169.447.44-234.45-249.91131.78-172.054.16-37.2599.83-127.94-16.13-206.27-41.89
Accounts Payables 0909.78-104.97151.5925.66159.3455.09270.0884.2800000
Other Working Capital 1,615-1,156.84-526.45-11.35118.56-70.32-239.88-225.7-126.4-181.8847.31223.3945.77-66.05
Other Non Cash Items 3,305.594.06233.91-24.35-14.74-9.47188.89-810.82-712.81-351.16-268.09-341.95-325.599.08
Operating Cash Flow 10,650.14,860.052,917.383,782.643,753.612,711.12,229.962,346.351,998.651,314.79900.57896.24380.15302.99
Investing Activities:
Investments In Property Plant And Equipment -1,550-1,291.63-8,414.21-1,210.33-257.63-1,512.82-380.02-250.96-497.47-236.41-130.84-519.33-78.43-66.39
Acquisitions Net -14,061.3-5,668-6,554.91-102.95-2.81-213.73-30.73-5,279.58350.30000
Purchases Of Investments -514.30-300-2,677.73-3,733.92-381-447.67-1,074.69-1,394.84-207.23-792.91-332.32-328.41-140.94
Sales Maturities Of Investments 12,870.3484.065,204.39795.87774.23,260.79797.3694.567.70021.9436.560.05
Other Investing Activites 36.3-12,069.65243.72-0.96-13.4279.6410.619.717.024.512.422.2813.590
Investing Cash Flow -799.7-18,545.22-9,821.01-3,196.1-3,233.581,232.88-50.51-5,900.97-1,841.1-439.13-921.33-827.43-356.69-207.28
Financing Activities:
Debt Repayment -4,059.314,636.998,1783350.1-86.02-2,002.143,734.74-65.09-54.75-20.58-24.07-27.41
Common Stock Issued 045.4322.7871.96008.920000000
Common Stock Repurchased 00000-1,016.7700000000
Dividends Paid -1,000.50-999.11-816.23-746.79-469.7900-169.12-830.78000-58.32
Other Financing Activities -3,753.4-884.63-321.4234.24-77.26-1,773.33-217.31-102.62-2.42-1.2-0.18-2.46-7.120
Financing Cash Flow -8,813.213,797.796,880.25-446.99-823.95-3,345.91-2,210.533,632.12-236.63-836.984.57-23.04-31.19-85.73
Other Information:
Effect Of Forex Changes On Cash 0074.900005.15000000
Net Change In Cash 1,054.95382.2351.52139.55-303.92598.07-31.0882.65-65.2538.68-16.1945.77-7.730
Cash At End Of Period 1,997.4942.45560.22508.7369.15673.0775106.0823.4288.6749.9966.1820.4193.26